Cardiovascular Disease and COVID-19: Issues in Women
COVID-19, although primarily a respiratory illness, has myriad cardiovascular manifestations. Underlying comorbidities like hypertension, diabetes, and underlying cardiovascular disease are associated with higher mortality. Diabetes confers greater risk in women than men. Myocardial injury is seen in 17 to 36% of patients and is associated with higher mortality. Acute coronary syndromes (ACS) pose diagnostic and therapeutic challenges in the setting of the COVID-19 pandemic. Case reports of myocarditis have been documented. The sex differences in these common presentations have not been disaggregated and such evaluation is warranted to elucidate future interventions.
09 October 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J 2020; 41 (19) 1798-1800
- 2 Li B, Yang J, Zhao F. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020; 109 (05) 531-538
- 3 Atri D, Siddiqi HK, Lang J, et al. COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci 2020 (e-pub ahead of print). doi: https://doi.org/10.1016/j.jacbts.2020.04.002
- 4 Wu, M, Huang S, Liu J, et al Association between comorbidities and the risk of death in patients with COVID-19: sex-specific differences. medRxiv2020 doi: https://doi.org/10.1101/2020.05.22.20109579
- 5 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229) 1054-1062
- 6 Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol 2020 (e-pub ahead of print). doi: 10.1001/jamacardio.2020.0950
- 7 Shaobo S, Qin M, Cai Y. et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J 2020; 41: 2070-2079
- 8 Lala A, Johnson KW, Januzzi JL. et al. Mount Sinai COVID Informatics Center. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 2020; 76 (05) 533-546
- 9 Mohanan PP, Mathew R, Harikrishnan S. et al. Kerala ACS Registry Investigators. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J 2013; 34 (02) 121-129
- 10 Bangalore S, Sharma A, Slotwiner A. et al. ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med 2020; 382 (25) 2478-2480
- 11 Acute Coronary Syndromes in COVID-19: Treatment Considerations. Available at: https://www.youtube.com/embed/WYx4xOn97aE?rel=0&autoplay=1. Accessed September 17, 2020
- 12 Stefanini GG. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation 2020; (e-pub ahead of print) DOI: 10.1161/CIRCULATIONAHA.120.047525.
- 13 Hamadeh A, Aldujeli A, Briedis K. et al. Characteristics and outcomes in patients presenting with COVID-19 and ST-segment elevation myocardial infarction. Am J Cardiol 2020; 131: 1-6
- 14 Prieto-Lobato A. A case series of stent thrombosis during the COVID-19 pandemic. J Am Coll Cardiol 2020; (e-pub ahead of print) DOI: 10.1016/j.jaccas.2020.05.024.
- 15 Loghin C, Chauhan S, Lawless SM. Pseudo-acute myocardial infarction in a young COVID-19 patient. J Am Coll Cardiol 2020 (e-pub ahead of print). doi: https://doi.org/10.1016/j.jaccas.2020.04.015
- 16 Zendjebil S, Zeitouni M, Batonga M, et al. Acute multi-vessel coronary occlusion revealing COVID-19 in a young adult. J Am Coll Cardiol 2020 (e-pub ahead of print). doi: https://dx.doi.org/10.1016%2Fj.jaccas.2020.06.002
- 17 Guagliumi G, Sonzogni A, Pescetelli I, Pellegrini D, Finn AV. Microthrombi and ST-segment elevation myocardial infarction in COVID-19. Circulation 2020; 142 (08) 804-809
- 18 ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 pandemic. Available at: https://escardio.org/Education/COVID-19. Accessed September 17, 2020
- 19 Kerkar PG, Naik N, Alexander T, et al. Cardiological Society of India: document on acute MI care during COVID-19. Indian Heart Journal 2020 (e-pub ahead of print). doi: https://doi.org/10.1016/j.ihj.2020.04.009
- 20 Hu H, Ma F, Wei X, et al. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J2020 (e-pub ahead of print). doi: https://doi.org/10.1093/eurheartj/ehaa190
- 21 Inciardi RM, Lupi L, Zaccone G. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020; (e-pub ahead of print) DOI: 10.1001/jamacardio.2020.1096.
- 22 Zeng J, Liu Y-X, Yuan J, et al. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Infection2020 (e-pub ahead of print). doi: https://dx.doi.org/10.1007%2Fs15010-020-01424-5
- 23 Tavazzi G, Pellegrini C, Maurelli M. et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 2020; 22 (05) 911-915
- 24 Sala S, Peretto G, Gramegna M. et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J 2020; 41 (19) 1861-1862
- 25 Deng Q, Hu B, Zhang Y. et al. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol 2020; (e-pub ahead of print) DOI: 10.1016/j.ijcard.2020.03.087.
- 26 Valentina O, Puntmann. M. Carerj L. et al. Outcomes of cardiovascular magnetic resonance imaging patients recently recovered from corona virus disease2019 (COVID-19). JAMA Cardiol 2020; (e-pub ahead of print) DOI: 10.1001/jamacardio.2020.3557.
- 27 Siddiqi HK, Mehra MR, COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant 2020 (e-pub ahead of print). doi: https://dx.doi.org/10.1016%2Fj.healun.2020.03.012
- 28 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China. JAMA 2020; 323 (11) 1061-9
- 29 Gao L, Jiang D, Wen XS. et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res 2020; 21 (01) 83
- 30 Ruan Q, Yang K, Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China: Intensive Care Medicine; 2020
- 31 Fried JA, Ramasubbu K, Bhatt R. et al. The variety of cardiovascular presentations of COVID-19. Circulation 2020; 141 (23) 1930-1936
- 32 Medina de Chazal H, Del Buono MG, Keyser-Marcus L. et al. Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review. J Am Coll Cardiol 2018; 72 (16) 1955-1971
- 33 Giustino G, Croft LB, Oates CP. et al. Takotsubo Cardiomyopathy in COVID-19. J Am Coll Cardiol 2020; (e-pub ahead of print) DOI: 10.1016/j.jacc.2020.05.068.
- 34 Global Health 5050 COVID-19 Sex-Disaggregated Data Tracker. Available at:http://globalhealth5050.org/covid19. Accessed September 17, 2020
- 35 Joe W, Kumar A, Rajpal S, Mishra US, Subramanian SV. Equal risk, unequal burden? Gender differentials in COVID-19 mortality in India. J Glob Health Sci2020 (e-pub ahead of print). doi: https://doi.org/10.35500/jghs.2020.2.e17
- 36 Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, Möller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics 2019; 13 (01) 2
- 37 Bhatia K, Zimmerman MA, Sullivan JC. Sex differences in angiotensin-converting enzyme modulation of Ang (1-7) levels in normotensive WKY rats. Am J Hypertens 2013; 26 (05) 591-598